Search Results - "Tyukavina, N. V."

Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors by Moiseyenko, V. M., Danilov, A. O., Baldueva, I. A., Danilova, A. B., Tyukavina, N. V., Larin, S. S., Kiselev, S. L., Orlova, R. V., Anisimov, V. V., Semenova, A. I., Shchekina, L. A., Gafton, G. I., Kochnev, V. A., Barchuk, A. S., Kanaev, S. V., Hanson, K. P., Georgiev, G. P.

“…Background: The use of genetically modified autologous tumor cells appears to be a promising approach for cancer therapy. A phase I/II trial was undertaken to…”
Get full text

Vozmozhnosti ispol'zovaniya tsetuksimaba dlya lecheniya bol'nykh kolorektal'nym rakom by R V Orlova, N V Tyukavina

“…Колоректальный рак (КРР) занимает 3-е место в мире среди онкологических заболеваний. Около 25% пациентов на момент постановки диагнозаимеют диссеминированную…”
Get full text

Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors: miscellaneous tumors by Moiseyenko, V M, Danilov, A O, Baldueva, I A, Danilova, A B, Tyukavina, N V, Larin, S S, Kiselev, S L, Orlova, R V, Anisimov, V V, Semenova, A I, Shchekina, L A, Gafton, G I, Kochnev, V A, Barchuk, A S, Kanaev, S V, Hanson, K P, Georgiev, G P

“…The use of genetically modified autologous tumor cells appears to be a promising approach for cancer therapy. A phase I/II trial was undertaken to define the…”
Get full text